SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Proteon Therapeutics, Inc. Announces Positive Phase 2 Trial Results of PRT-201 in Chronic Kidney Disease Patients Undergoing Surgical Placement of an Arteriovenous Fistula for Hemodialysis
Your Message